Navigation Links
Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
Date:6/30/2009

latelet therapy. As a result, the GRAVITAS study is the first multi-center, placebo-controlled study to determine whether tailored antiplatelet therapy based on the results of the company's VerifyNow System and P2Y12 Test reduces major cardiovascular adverse events post-PCI. The trial is being coordinated by Scripps Advanced Clinical Trials.

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product for prasugrel and FDA-cleared products for aspirin, Plavix, ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis. 

    CONTACT:
    Jules Abraham
    Lippert/Heilshorn & Associates
    212-838-3777
    jabraham@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    858-404-8260
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
2. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
3. Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
4. Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obamas Announcement on Healthcare Reform
5. ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
6. Spherix Announces Positive Phase 2 Study Results
7. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
8. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
9. CoAxia, Inc. Announces $21.5M Series D Financing
10. Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
11. Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Biovista Inc.,today announced that it was awarded the ... 2009 New England Venture Summit, held on December ... edge private companies,driving the future of innovation, was ... privately held companies that play a leading role ... sectors. , "We are ...
(Date:12/16/2009)... PARSIPPANY, N.J. and ANN ARBOR, Mich., Dec. 16 ... GSK ) and NanoBio Corporation today announced an ... Canada for the over-the-counter (OTC) use of NB-001, ... in the treatment of cold sores. Developed by ... virus that causes cold sores, herpes labialis ...
(Date:12/16/2009)... 16 MAQUET Cardiovascular LLC, a ... that it has signed a three-year single ... leading supply contracting company, for MAQUET,s market-leading ... VASOVIEW products assist healthcare providers in obtaining ... using only small incisions. This allows for ...
Breaking Medicine Technology:Biovista Inc. Named Top Innovator in Life Sciences 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4FaxBack Awarded 26quot 3BBest of Show 26quot 3B at ITEXPO West 2009 57042 1FaxBack Awarded 26quot 3BBest of Show 26quot 3B at ITEXPO West 2009 57042 2FaxBack Awarded 26quot 3BBest of Show 26quot 3B at ITEXPO West 2009 57042 3Hard Rock International Marks 10 Years Of Support For Breast Cancer Awareness And Research With 2009 PINKTOBER 28TM 29 Campaign Featuring Melissa Ethe 57038 1Hard Rock International Marks 10 Years Of Support For Breast Cancer Awareness And Research With 2009 PINKTOBER 28TM 29 Campaign Featuring Melissa Ethe 57038 2Hard Rock International Marks 10 Years Of Support For Breast Cancer Awareness And Research With 2009 PINKTOBER 28TM 29 Campaign Featuring Melissa Ethe 57038 3Hard Rock International Marks 10 Years Of Support For Breast Cancer Awareness And Research With 2009 PINKTOBER 28TM 29 Campaign Featuring Melissa Ethe 57038 4Lilly Names New Business Leaders 57034 1Lilly Names New Business Leaders 57034 2Lilly Names New Business Leaders 57034 3Lilly Names New Business Leaders 57034 4Lilly Names New Business Leaders 57034 5Lilly Names New Business Leaders 57034 6Lilly Names New Business Leaders 57034 7Lilly Names New Business Leaders 57034 8
... THE WOODLANDS, Texas--(BUSINESS WIRE)--Jun 11, 2007 - Repros,Therapeutics ... month study of Proellex in the treatment of,endometriosis. ... and has completed six months of dosing. The,study ... as a,positive control arm. The positive control was ...
... 2007 - Neurogen,Corporation (Nasdaq: NRGN) today announced that ... the Company's lead compound,for the treatment of insomnia, ... of the Associated Professional Sleep Societies,(APSS) in Minneapolis, ... chronic insomnia patients are currently being,conducted by the ...
Other Medicine Technology:Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 4
(Date:12/16/2009)... SPRINGFIELD, Mass., Dec. 16 MassMutual,s Retirement ... new RetireSmart(SM) participant engagement platform in Q2 2010. ... of enrollment, transition and investment change materials in ... the option to choose from a menu of ... to their own participant population. The new RetireSmart ...
(Date:12/16/2009)... (Boston) Boston University School of Medicine,s (BUSM) ... grant from the National Heart, Lung, and Blood ... from patients with lung disease. , Darrell ... and Gustavo Mostoslavsky, MD, PhD, assistant professor of ... grant award. Together Kotton and Mostoslavsky lead a ...
(Date:12/16/2009)... staffing agency, is honored to announce that Chris Wepfer and ... the Year in Healthcare Traveler magazine’s 2009 Recruiters of the ... has received such honors and the first for Jackie. ... ... Medical Solutions, a national healthcare staffing agency, is honored to ...
(Date:12/16/2009)... 16 Medizone International, Inc. (OTC Bulletin ... of Directors and the Board of Medizone New ... International Inc. holds a 50% interest, agreed on ... and reconvey to Medizone International all global marketing ... International,s Chairman, Edwin G. Marshall said, "Time has ...
(Date:12/16/2009)... interval lessens complication risks , , TUESDAY, Dec. 15 (HealthDay News) ... such a profound impact on your life that you just ... new study suggests that you might want to wait at ... than 11 months could be even better. , The ... than six months, the chances of the baby dying, being ...
Breaking Medicine News(10 mins):Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3
... Today, 1.1 billion people,lack access to safe water ... though many existing technologies and approaches can ensure ... In a report released,today, scientists and development experts ... and hygiene (WASH) sector. "The,good news is there ...
... Partner to, Combat Counterfeit Drugs, ALEXANDRIA, ... (NCPA), on the heels of the first annual,"Protect ... pharmacy robberies,and burglaries, has partnered with the United ... combat counterfeited and pirated,prescription drugs., "Counterfeit drugs ...
... WebMD Health Corp. (Nasdaq:,WBMD) and HLTH Corporation (Nasdaq: ... scheduled to participate at the Third Annual Needham & ... 2008 at 8:00 am ET., Investors, analysts and ... audio broadcast of the presentation over the Internet. The ...
... of brain tissue samples from chronic alcoholics reveals changes ... and suggests a potential treatment target, according to ... Reporting in Alcoholism: Clinical and Experimental Research, the scientists ... involved in cell signaling and development is found at ...
... Announces 2008,Journalistic Achievement Awards, NEW YORK, May ... Show are among winners receiving top honors,in the ... for Aesthetic Plastic Surgery (ASAPS). Selected from among ... their awards on May,6th, at ASAPS, Annual Meeting ...
... Pa., May 2 The Association for,Community Affiliated ... a,risky proposal by the State Department of Public ... many as one million Medicaid,enrollees in the Commonwealth., ... prescription drugs,away from the health plans and urge ...
Other Medicine News:Health News:Improving Access to Safe Water, Sanitation, Hygiene Requires Better Decision-Making Tools, Finds Joint Wilson Center-Pacific Institute Report 2Health News:US Chamber of Commerce Joins 'Protect Your Pharmacy Now!' Initiative 2Health News:US Chamber of Commerce Joins 'Protect Your Pharmacy Now!' Initiative 3Health News:Analysis of alcoholics' brains suggests treatment target 2Health News:Aesthetic Society Awards Journalists' Commitment to Patient Education 2Health News:Aesthetic Society Awards Journalists' Commitment to Patient Education 3Health News:Pennsylvania Pharmacy 'Carve-out' Poses Risks for Commonwealth's Neediest Citizens and Taxpayers, National Organization Testifies 2
... Oscors proprietary quadripolar pacing wire ... pacing and sensing in the ... two bipolar wires in one ... the atrium and ventricle are ...
... TME 227 T is a ... temporary cardiac pacing and monitoring ... The TME 227 T features ... myocardium, which allows safe and ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: